PHILADELPHIA — Fine, Kaplan and Black, R.P.C. announced July 10 that claim forms are now being accepted for class action settlements totaling $533 million.
If you paid or reimbursed for certain prescription generic drugs in the United States between May 1, 2009 and December 31, 2019, you could be eligible for a payment from the settlements, which were authorized by a federal court.
Additional details about eligibility and claim submission procedures are available through the law firm.
